Related Experiment Videos
[Painless infarction in antiphospholipid syndrome]
A Dacosta1, J M Guy, H Rousset
1Service de cardiologie, Hôpital Nord, CHRU Saint-Etienne, Saint-Priest-en-Jarez.
Archives Des Maladies Du Coeur Et Des Vaisseaux
|December 1, 1993
Insights
This case study highlights myocardial infarction caused by antiphospholipid syndrome-induced coronary thrombosis. Effective anticoagulant therapy monitoring is crucial for managing this rare cardiac condition.
Area of Science:
- Cardiology
- Immunology
- Hematology
Background:
- Antiphospholipid syndrome (APS) is an autoimmune disorder associated with an increased risk of thrombosis.
- Cardiac involvement in APS, particularly coronary artery disease, is uncommon but serious.
Observation:
- A rare case of myocardial infarction (heart attack) is presented, directly resulting from coronary artery thrombosis.
- The thrombosis was confirmed to be caused by antiphospholipid syndrome.
Findings:
- The study reviews the link between cardiac pathology, specifically coronary disease, and the presence of antiphospholipid antibodies.
- This case underscores the potential for APS to manifest as acute coronary events.
Implications:
- Emphasizes the critical importance of vigilant monitoring of anticoagulant therapy in patients with APS.
- Highlights the need for increased awareness among clinicians regarding cardiac manifestations of APS.
- Suggests potential for improved diagnostic and therapeutic strategies for APS-related cardiovascular complications.
Abstract:
The authors report a rare case of myocardial infarction secondary to coronary thromboses caused by the antiphospholipid syndrome. The relations between the cardiac pathology, especially the coronary disease, and antiphospholipid antibodies are recalled. The importance and methods of monitoring the anticoagulant therapy are emphasised.